IP Library Granted Patent US 8,603,079
Granted Patent B2
US 8,603,079 · App. 13/757,169 · Granted Dec 10, 2013

Appratus for treating hyperopia and presbyopia via laser tunneling

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,603,079
App. No.
13/757,169
Granted
Dec 10, 2013
Kind
B2
Abstract

A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.

Claims (10)

1. A surgical system for treating an eye in need of a physiological or vision correction, comprising:

a source of treatment energy for cutting or ablating an anatomic structure of an eye;

a measuring device for facilitating a determination of a thickness of the anatomic structure; and

a delivery system having an output end configured to facilitate delivery of treatment energy from the source to an area of the anatomic structure in need of a physiological or vision correction;

wherein the delivery system responds to the measuring device by ablating more than 90% of the thickness of the anatomic structure, but not an underlying structure, to form a tunnel ablation; and

wherein the output end (a) provides a spot size of 0.8 mm or less and (b) applies a wavelength and power corresponding to the tunnel ablation having a bottom surface with a u-shape or a flattened bottom and a radius of curvature less than about 75 mm.

2. A surgical system as defined in claim 1 , wherein the source of treatment energy comprises an Er:YAG laser.

3. A surgical system as defined in claim 1 , wherein the spot size is in a range with a low end at about 0.4 mm.

4. A surgical system as defined in claim 1 , wherein the output end has a fiber tip and a tapering shape with a distal output surface perpendicularly disposed relative to a longitudinal axis of the fiber tip.

5. The surgical system as set forth in claim 4 , wherein the tapering shape is conical.

Assignments (5)
SECURITY INTEREST Recorded Oct 30, 2019
From: BIOLASE, INC.
To: PACIFIC MERCANTILE BANK
Reel/Frame 050879/0223 →
SECURITY INTEREST Recorded Nov 16, 2018
From: BIOLASE, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 047588/0192 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2018
From: WESTERN ALLIANCE BANK
To: BIOLASE, INC.
Reel/Frame 048101/0027 →
SECURITY INTEREST Recorded Mar 7, 2018
From: BIOLASE, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 045514/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2013
From: VAN VALEN, MARCIA ANGELA
To: BIOLASE, INC.
Reel/Frame 029779/0803 →